/Press Releases

REAL-WORLD DATA FROM SURVEILLANCE STUDY CONFIRMS EXCELLENT SAFETY AND TOLERABILITY PROFILE OF REMfresh® ION-POWERED MELATONIN™ AT 12 MONTHS

REAl-WORLD DATA FROM SURVEILLANCE STUDY CONFIRMS EXCELLENT SAFETY AND TOLERABILITY PROFILE OF REMfresh® ION-POWERED MELATONIN™ AT 12 MONTHS   REMfresh® Safety Update at 12 Months (REMSU-12) for REMfresh® reconfirms safety profile seen in REMSU-6. No serious adverse events for [...]

2019-04-15T11:36:21-07:00July 23rd, 2018|0 Comments

PATIENT-REPORTED OUTCOMES STUDY, PRESENTED AT SLEEP 2018, PROVIDES CONFIRMATORY REAL-WORLD EVIDENCE OF THE PREVIOUSLY PRESENTED 7-HOUR ACTION OF REMfresh®, THE FIRST CONTINUOUS RELEASE AND ABSORPTION MELATONIN™

PATIENT-REPORTED OUTCOMES STUDY, PRESENTED AT SLEEP 2018, PROVIDES CONFIRMATORY REAL-WORLD EVIDENCE OF THE PREVIOUSLY PRESENTED 7-HOUR ACTION OF REMfresh®, THE FIRST CONTINUOUS RELEASE AND ABSORPTION MELATONIN™    More than 77 percent of patients in the REMfresh® Patient Reported Outcomes [...]

2019-04-05T07:58:28-07:00June 6th, 2018|0 Comments